The FDA on Tuesday approves Ozempic, the weight loss drug made by Novo Nordisk, for the treatment of chronic kidney disease ...

HHS adds 15 drugs to Medicare Part D price negotiations, targeting cost reductions under the Inflation Reduction Act. New ...

The data from the early-stage obesity study of amycretin is a short-term win for Novo Nordisk amid other factors that weigh ...

Wall Street investors, spurred on by Trump's pro-business agenda, could be ignoring real risks posed by the president.

Robert F. Kennedy Jr. told the Senate Finance Committee that he is not anti-vaccine during his confirmation hearing for ...

Michael Batnick said the outperformance of consumer discretionary stocks relative to consumer staples is "the most bullish ...

Hers shares information about the average weight for women in the U.S., what women believe the ideal weight is, and the ...

Trump’s pick to lead the Health Department is targeting a multibillion-dollar ad market that’s one of the biggest spenders on ...

"Investors are questioning the long-term impact of revolutionary weight loss drugs like Ozempic on food and beverage ... and this is the chart that is giving me confidence," Batnick said in ...

As I reported in yesterday’s Mail, another bespoke medical service is couriering Ozempic and other weight ... app for celebrities – were ‘off the charts’. She ended up having a drink ...

Four of the top 10 drugs by prescription sales in 2025 will be from the new incretin class, according to the latest analysis by Evaluate. Consensus forecasts for Ozempic, Wegovy, Mounjaro and Zepbound ...

It charts transformative changes since the start of the 20th ... “Anyone ordering goods online knows that we need Ozempic not ...